124 related articles for article (PubMed ID: 12951327)
1. Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii.
Spence RP; Towner KJ
J Antimicrob Chemother; 2003 Oct; 52(4):687-90. PubMed ID: 12951327
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
[TBL] [Abstract][Full Text] [Related]
3. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of bacterial kill when modelling the bronchopulmonary pharmacokinetic profile of moxifloxacin and levofloxacin against parC-containing isolates of Streptococcus pneumoniae.
Deryke CA; Du X; Nicolau DP
J Antimicrob Chemother; 2006 Sep; 58(3):601-9. PubMed ID: 16857688
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.
Walkty A; Boyd DA; Gravel D; Hutchinson J; McGeer A; Moore D; Simor A; Suh K; Taylor G; Miller M; Mulvey MR;
Diagn Microbiol Infect Dis; 2010 Apr; 66(4):419-24. PubMed ID: 20226332
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii.
Mak JK; Kim MJ; Pham J; Tapsall J; White PA
J Antimicrob Chemother; 2009 Jan; 63(1):47-54. PubMed ID: 18988680
[TBL] [Abstract][Full Text] [Related]
7. Diversity of moxifloxacin resistance during a nosocomial outbreak of a predominantly ribotype ARU 027 Clostridium difficile diarrhea.
Carman RJ; Genheimer CW; Rafii F; Park M; Hiltonsmith MF; Lyerly DM
Anaerobe; 2009 Dec; 15(6):244-8. PubMed ID: 19818865
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
[TBL] [Abstract][Full Text] [Related]
9. In vivo activity of gemifloxacin, moxifloxacin and levofloxacin against pneumococci with gyrA and parC point mutations in a sepsis mouse model measured with the all or nothing mortality end-point.
Alkorta M; Giménez MJ; Vicente D; Aguilar L; Pérez-Trallero E
Int J Antimicrob Agents; 2005 Feb; 25(2):163-7. PubMed ID: 15664487
[TBL] [Abstract][Full Text] [Related]
10. Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii.
Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
J Antimicrob Chemother; 2004 Oct; 54(4):821-3. PubMed ID: 15355942
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002].
Akan OA
Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260
[TBL] [Abstract][Full Text] [Related]
12. In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant.
Schafer J; Hovde LB; Simonson D; Rotschafer JC
Diagn Microbiol Infect Dis; 2008 Feb; 60(2):155-61. PubMed ID: 17910998
[TBL] [Abstract][Full Text] [Related]
13. Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing.
Zinner SH; Lubenko IY; Gilbert D; Simmons K; Zhao X; Drlica K; Firsov AA
J Antimicrob Chemother; 2003 Oct; 52(4):616-22. PubMed ID: 12951352
[TBL] [Abstract][Full Text] [Related]
14. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
15. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
[TBL] [Abstract][Full Text] [Related]
16. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
Navon-Venezia S; Leavitt A; Carmeli Y
J Antimicrob Chemother; 2007 Apr; 59(4):772-4. PubMed ID: 17353223
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of PGE 9262932 and fluoroquinolones against Canadian clinical Streptococcus pneumoniae isolates, including molecularly characterized ciprofloxacin-resistant isolates.
Adam HJ; Schurek KN; Decorby MR; Weshnoweski B; Vashisht R; Karlowsky K; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2006 Jul; 58(1):202-4. PubMed ID: 16636082
[TBL] [Abstract][Full Text] [Related]
18. Variation in the mutation frequency determining quinolone resistance in Chlamydia trachomatis serovars L2 and D.
Rupp J; Solbach W; Gieffers J
J Antimicrob Chemother; 2008 Jan; 61(1):91-4. PubMed ID: 18033786
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
20. Development of a pyrosequencing assay for rapid assessment of quinolone resistance in Acinetobacter baumannii isolates.
Deccache Y; Irenge LM; Savov E; Ariciuc M; Macovei A; Trifonova A; Gergova I; Ambroise J; Vanhoof R; Gala JL
J Microbiol Methods; 2011 Jul; 86(1):115-8. PubMed ID: 21514328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
